Percutaneous celiac plexus block using controllable curved needle for refractory carcinomatous upper abdominal pain:report of 18 cases
10.3969/j.issn.1008-794X.2014.10.019
- VernacularTitle:可控弯针经皮穿刺腹腔神经丛毁损术治疗上腹部癌痛18例
- Author:
Zetao WU
;
Huanxiang LI
;
Fengquan LV
;
Wujun LIU
;
Yanshou MA
;
Zhengyin LIAO
- Publication Type:Journal Article
- Keywords:
celiac plexus block;
carcinomatous pain;
ethanol;
CT
- From:
Journal of Interventional Radiology
2014;23(10):916-919
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of CT-guided percutaneous celiac plexus block (NCPB) using 25 G controllable curved needle together with 22 G straight needle in treating refractory carcinomatous upper abdominal pain. Methods A total of 18 patients with advanced refractory carcinomatous upper abdominal pain were enrolled in this study. The carcinomatous upper abdominal pain failed to the three-step analgesic therapy. Guided by CT scan, percutaneous injection of ethanol with a 25 G controllable curved needle to destroy celiac plexus was carried out in all patients. According to WHO pain relief standards, the relieving degree of pain was evaluated before NCPB and 2 weeks, one, 2, 3 and 6 months after NCPB. The results were analyzed. Results The technical success rate was 100%. The short-term (within 2 weeks) efficacy rate was 88.8%and the complete remission rate was 38.8%. The long-term (over 3 months) efficacy rate was 50% and the complete remission rate was 20%. No severe complications occurred. Conclusion For refractory carcinomatous upper abdominal pain, CT-guided percutaneous celiac plexus block is a simple, safe and effective treatment.
